Morgan Stanley Says AI Data Centers Face a 38-Gigawatt Power Gap. These Industrial Stocks Fill It.

Morgan Stanley estimates U.S. data centers will need 68 gigawatts of power by 2026-2028, with a 38-gigawatt shortfall. This creates significant opportunities for industrial companies supplying power generation, distribution, and cooling equipment. GE Vernova, Eaton, and Vertiv are positioned to benefit from surging demand for turbines, electrical infrastructure, and thermal management systems needed to close the power gap.

08/20/2026, 8:05 AM • The Motley Fool

Is Joby Aviation the Best Growth Stock in the Industrial Sector?

Joby Aviation, an electric vertical takeoff and landing (eVTOL) aircraft company, is making significant progress toward FAA certification and has diversified its growth strategy through the acquisition of defense technology company Resonant Sciences. While the stock trades at a high valuation of 62 times sales, analysts suggest urban air mobility could become a multi-trillion dollar market opportunity by 2050, making it a compelling but high-risk speculative investment for growth investors.

08/19/2026, 6:05 AM • The Motley Fool

WestKai Private Wealth Joins LPL Strategic Wealth

Financial advisor Don A. Harrell and his team at WestKai Private Wealth, managing approximately $400 million in assets, have joined LPL Financial's supported independence model, LPL Strategic Wealth, transitioning from Morgan Stanley. The San Clemente-based firm chose LPL for its technology platform, flexibility, and resources to enhance personalized client service.

08/05/2026, 8:55 AM • GlobeNewswire

Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering

Attovia Therapeutics, a clinical-stage biopharmaceutical company, priced its IPO at $17 per share, raising $289 million from 17 million shares. The company will begin trading on Nasdaq under ticker 'ATTO' on August 5, 2026. Attovia is developing biotherapeutics for immune-mediated diseases using its proprietary ATTOBODY platform, with lead programs targeting chronic pruritic diseases, atopic dermatitis, and inflammatory bowel disease.

08/04/2026, 8:50 PM • GlobeNewswire

Here's How a Small Bet on This Nuclear Stock Could Pay Off Big

Nuclear energy is experiencing a revival driven by climate goals and AI's rising energy demands, with analysts projecting a $10 trillion global opportunity. NuScale Power, the only U.S. company with regulatory approval to build small modular reactors (SMRs), is positioned to benefit significantly. However, the company faces execution challenges, has posted substantial operating losses, and has yet to break ground on commercial reactors, though a major 6-gigawatt project update is expected by year-end.

08/03/2026, 2:05 PM • The Motley Fool

Morgan Stanley Just Launched New Ethereum and Solana ETFs. Here's What It Could Mean for Crypto Investors.

Morgan Stanley launched spot ETFs for Ethereum and Solana with a 0.14% expense ratio, following its Bitcoin ETF debut in April. These ETFs offer advantages for crypto investors, including tax-free growth in Roth IRAs, simplified tax reporting, and integrated staking rewards. The move signals growing legitimacy for cryptocurrencies and expands investment options through Morgan Stanley's 16,000+ financial advisors.

08/02/2026, 1:04 PM • The Motley Fool

47 Analysts Cover Apple. Their Average Price Target Is Now Below the Stock Price, One Week Before Earnings.

Apple's average analyst price target of $319 has fallen below its current stock price of ~$320, an unusual situation for a major tech company. While 47 analysts still rate it a buy overall, the flat consensus suggests the stock's valuation multiple has already expanded significantly. With the company trading at 40x earnings and sitting 4% from record highs, the upcoming July 30 earnings report carries heightened importance, as good news may only confirm what's already priced in rather than drive further gains.

07/23/2026, 9:12 PM • The Motley Fool

Are SpaceX Bulls Deluding Themselves? This Wall Street Analyst Might Convince You So

SpaceX stock has fallen nearly 50% from its peak since IPO, trading below its $135 offering price. While Wall Street analysts issued bullish price targets averaging $278, Morgan Stanley forecasts no positive free cash flow until 2035 and estimates the company will need approximately $84 billion annually ($672 billion total) in external capital through 2034. The analysis suggests SpaceX's current $1.5 trillion valuation is difficult to justify given the decade-long cash burn projection, and the stock may continue declining as investors realize the company's ambitious goals remain decades away from profitability.

07/22/2026, 9:30 PM • The Motley Fool

What Bank Earnings Just Revealed About the Health of the American Consumer

Major banks JPMorgan Chase and Bank of America reported strong Q2 earnings, revealing resilient consumer spending across all income segments. Credit metrics improved significantly, with lower charge-off rates and increased debit/credit card volumes. Banks attribute strength to a stable labor market with ~4.2% unemployment and higher tax refunds, though executives acknowledge some lower-income consumers still face wage stagnation amid inflation.

07/22/2026, 6:15 AM • The Motley Fool

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Dyne Therapeutics, a clinical-stage neuromuscular disease company, announced a $300 million underwritten public offering of common stock with a 30-day option for underwriters to purchase an additional $45 million. Morgan Stanley, Jefferies, Evercore ISI, LifeSci Capital, and Raymond James are serving as joint book-running managers. The offering is subject to market conditions and SEC approval.

07/21/2026, 4:46 PM • GlobeNewswire

How Buying SpaceX Today Could More Than 10X Your Net Worth

SpaceX could deliver a 10x return if annual revenue reaches $3.6 trillion by 2040, aligning with Morgan Stanley's $3.4 trillion projection. Currently trading at $1.8 trillion market cap with $18.7 billion in 2025 revenue, the company would need a 5x price-to-sales ratio to reach an $18 trillion valuation. However, this scenario depends on successful execution of Starlink, Starship, and AI segments, with significant downside risk if any underperforms.

07/18/2026, 6:30 PM • The Motley Fool

What a $1,000 Investment in SpaceX Could Be Worth in 2030

SpaceX, which recently went public, operates three segments: space launch services, Starlink connectivity, and AI infrastructure. With 2025 revenue of $18.7 billion, Wall Street analysts project revenues between $330-474 billion by 2030. Under various valuation scenarios, a $1,000 investment today could grow to $1,830-$6,555 by 2030, though success depends on execution across all segments and faces risks from competition and capital intensity.

07/16/2026, 8:05 AM • The Motley Fool

Nasdaq Forecast: NDX Extends Gains After Cooler PPI

U.S. stocks extended gains following cooler-than-expected producer price inflation data, with PPI falling 0.3% monthly and 5.5% year-over-year. The Nasdaq futures rose 0.68% as markets scaled back Fed rate hike expectations. However, rising oil prices due to U.S.-Iran tensions pose inflation risks. Key movers included ASML gaining 3% on strong earnings, IBM tumbling 25% on profit warnings, Morgan Stanley up 1.5% on record results, and BlackRock rising 4% on better-than-expected earnings.

07/15/2026, 9:35 AM • Investing

Bitcoin Has Fallen 50% From Its Peak. History Points to What Comes Next.

Bitcoin has declined 50% from its October 2025 peak of $126,128, following the established halving cycle pattern. Historical data suggests recovery could take 2-3 years, with the next halving in April 2028 potentially catalyzing the next bull cycle. The cryptocurrency is increasingly acting like a traditional asset due to institutional adoption via spot Bitcoin ETFs (launched January 2024), improved regulatory clarity, and miners diversifying into AI computing contracts.

07/14/2026, 11:37 AM • The Motley Fool

A Downgrade Wave Says Bank Stocks Are Priced for Perfection Ahead of Q2 Earnings. Here's the Bear Case.

Oppenheimer downgraded major investment banks Goldman Sachs and Morgan Stanley from perform to underperform, citing valuations that are priced for perfection. The downgrades reflect concerns that investment banking revenues, boosted by the SpaceX IPO and strong Q1 2026 results, may not sustain if capital markets activity slows due to higher bond yields or delayed AI IPOs. Oppenheimer recommends rotating into super-regional banks and alternative asset managers with greater upside potential.

07/09/2026, 5:14 AM • The Motley Fool